Switch to
More onapp

How to use scorecard? Learn more

Genomic Valley Biotech Ltd

GVBL
Health CareBiotechnology
SmallcapWith a market cap of ₹31 cr, stock is ranked 3,853
High RiskStock is 3.58x as volatile as Nifty
102.901.40 (+1.38%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CareBiotechnology
SmallcapWith a market cap of ₹31 cr, stock is ranked 3,853
High RiskStock is 3.58x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
119.24
PB RatioPB Ratio
8.81
Dividend YieldDiv. Yield
Sector PESector PE
51.90
Sector PBSector PB
6.61
Sector Div YldSctr Div Yld
0.52%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Genomic Valley Biotech Ltd is conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market

Financial TrendFinancial statements 

20212022202320240.210.572.760.17-0.57-0.010.650.02
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 9.53%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Board Meeting 
Announced OnDec 2, 2024

Genomic Valley Biotech Ltd - 539206 - Board Meeting Intimation for Notice Of Board Meeting Of The Company Under Regulation 29 Of The Securities And Exchange Board Of India (LODR) Regulations,2015 | Download

Genomic Valley Biotech Ltd - 539206 - Board Meeting Intimation for Notice Of Board Meeting Of The Company Under Regulation 29 Of The Securities And Exchange Board Of India (LODR) Regulations,2015 | Download

Insider Trading / SAST 
Announced OnOct 28, 2024

Genomic Valley Biotech Ltd - 539206 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | Download

Genomic Valley Biotech Ltd - 539206 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | Download

Insider Trading / SAST 
Announced OnOct 21, 2024

Genomic Valley Biotech Ltd - 539206 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | Download

Genomic Valley Biotech Ltd - 539206 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | Download

See all events